| Micro-channel |
 |
|
|
|
|
|
| |
| 803.7 billion! China's drug terminal market grew by 7.8% in the first half of the year |
| |
| Author：中國銘鉉 企劃部 Release Time：2017-8-7 14:42:23 Number Browse：638 |
| |
Medical network August 7 - on August 4, by the CFDA institute of medicine economic south guidance, m a network to undertake the development of Chinese pharmaceutical market of 2017 blue book (hereinafter referred to as the "blue book") press conference held in guangzhou, pharmaceutical industry development, the hospital drug use and change of retail pharmacies in depth interpretation.
China's drug terminal market sales have improved but the year-on-year growth rate has slowed, according to zhang gai, general manager of minnet. In 2016, the sales volume of drug terminal market in China was 149.75 billion yuan, up by 8.3% year on year, and 803.7 billion yuan in the first half of 2017, up 7.8% year on year.
Medicine economic newspaper reporter learns in the interview, the second half of this year, the challenge for the pharmaceutical industry remains unchanged, in drug bidding price, health insurance fees, cancellation policy trends such as drug addition, drugs are unlikely to end market annual growth is boosted sales growth and will continue to be maintained at 7.5% ~ 7.8%.
Last year, China's drug terminal market reached 14.975 billion
In 2011-2015, the growth of sales revenue of China's pharmaceutical industry (including the seventh-largest sub-sector) showed a year-on-year decline, falling from 26.1% in 2011 to 9.0% in 2015. In 2016 China's pharmaceutical industry sales income is 2.9463 trillion yuan, up 10.3% from a year earlier, the growth increased by 1.3% on the previous year, growth is higher than 5.4% of China's overall industrial growth, ended a slowing trend for five consecutive years, bottoming out.
From 2011-2016, China's drug market terminal sales increased from 809.7 billion yuan to 149.75 billion yuan, and the compound growth rate reached 13.08% in 6 years.
The first terminal sales account for the largest proportion
According to the data "blue book", the first terminal for public hospital terminal, pharmaceutical sales of 1.024 trillion yuan in 2016, including two markets of the city public hospital and public hospitals at the county level, its size is 767.5 billion yuan and 256.5 billion yuan respectively.
The second terminal is the retail pharmacy terminal, with 3337.5 billion yuan of pharmaceutical sales in 2016, including two market for physical pharmacies and online pharmacies, with the drug size of 3332.7 billion yuan and 4.8 billion yuan respectively.
The third terminal public primary care for terminal, drug sales of 136 billion yuan in 2016, including the urban community health service centers and two market towns and townships, the scale of 50.1 billion yuan and 85.9 billion yuan respectively. There are no private hospitals, village clinics and private clinics in the big three terminals.
From the implementation of drug sales three terminal sales distribution, the first terminal public hospital terminal is the most important drug sales terminals, share in the market, the largest share of the terminal after reaching the historical high of 69.0% in 2014, share a slight decline in nearly two years, accounted for 68.4% in 2016, the first half of 2017 accounted for 68.1%; The terminal of the second terminal retail pharmacy, although the sales volume of the period increased year by year, the proportion of the drug sales decreased year by year, from 24.7% in 2011 to 22.5% in 2016 and 2017. The third terminal, public primary medical terminal, accounted for 9.1% in 2016 and 9.4% in 2017.
"Blue book" analysis, points out that in 2016 the city public hospital terminal continue to be deepen, classification, diagnosis and treatment of advancing the reform of public hospitals, health care and hospital medicine zero addition, the influence of such policy since 2016, our country the first terminal sales to maintain growth, but growth is slowing, 2016 sales of 1.024 trillion yuan, up 7.6%; In the first half of 2017, it reached 547.9 billion yuan, up 7.2% year on year. However, the growth of urban public hospital hospitals in the first terminal was significantly slower, with sales of 767.5 billion yuan in 2016, up 6.1 percent year on year. In the first half of 2017, it was 406.8 billion yuan, up 6.0% year on year. At the same time, our country public hospital pharmaceutical sales at the county level significantly faster than the growth of city public hospital in the market, but its growth also showed a trend of decline year by year, at the county level public hospital drug sales of 256.5 billion yuan in 2016, year-on-year growth of 12.3%. In 2017, it was 141.1 billion yuan, up 10.9 percent year on year.
The terminal of the second terminal retail pharmacy has been growing since 2016, but the growth rate has also slowed. In 2016, the sales volume of the second terminal was 337.5 billion yuan, up 8.5% year on year. Sales in the first half of 2017 were 181.3 billion yuan, up 8.0 percent year on year. In the second terminal, the market sales in the physical pharmacy market reached 332.7 billion yuan in 2016, an increase of 8.1% year on year. Sales in the first half of 2017 were 177.8 billion yuan, up 7.5% year on year. On the other hand, drug sales in the online pharmacy market in 2016 were 4.8 billion yuan, with a growth rate of 50.0%, and 3.5 billion yuan in the first half of 2017, with a growth rate of 45.8%.
After the general office of the state council issued the guidelines on promoting the construction of the grading system ", requires focusing on strong grassroots grading medical service system, to strengthen the construction of health service ability, the policy is put forward for basic-level hospital drug sales market has brought good opportunities for development. The growth of public primary-level medical terminal sales is significantly faster than that of the other two terminal markets. In particular, the sales volume of the third terminal public primary medical terminal in 2016 was 135.9 billion yuan, with a growth rate of 13.2%. In the first half of 2017, sales reached 74.5 billion yuan, up 11.3% year on year. Among them, the urban community health service center/station sales volume of 2016 was 501 billion yuan, with growth rate of 14.3%. Sales reached 28.4 billion yuan in the first half of 2017, with a growth rate of 12.0%. Sales of township hospitals in 2016 were 85.9 billion yuan, up 12.6% year on year. Sales reached 46.1 billion yuan in the first half of 2017, up 11.0% year on year.
Terminal sales growth was the fastest
Urban public hospital market is still the first big drug sales terminals, the sum of total more than half of the current city public hospital still is the first selection of patients, however, as the classification and treatment policy gradually, grassroots medical institutions use scale of rapid growth.
As a result, public primary-level medical terminal drugs, despite small sales, are the fastest growing in the three main terminals, with market share rising from 6.6% in 2011 to 9.1% in 2016. With the deepening of public hospital reform and the promotion of the hierarchical medical system, the market share of the public primary medical terminal market is expected to continue to rise. Among them, the city community health center/station market medicine is relatively small, but is gradually being taken seriously by enterprises, and the growth rate of market sales in recent years is significantly faster than that of urban public hospitals. In towns and townships, on the other hand, benefit from the new health care reform policy, the drug sales increase rapidly in recent years, the six year compound growth rate of 16.1%, also far above the city public hospital pharmaceutical sales growth.
Drugstore chains are growing faster than online drugstores
In 2016, under the influence of the new GSP policy, the survival pressure of monomer pharmacies increased, and the chain rate and concentration of retail enterprises increased further. Among them, the proportion of independent pharmacies continued to decline to 50.63 percent, while the number of chain stores increased by 3.64 percentage points to 49.37 percent.
In addition, the entity of pharmacy drug market share declines year by year the trend, extrusion entities pharmacy by urban community market in recent years, electric business impact, health care, control the factors such as cost, overall sales growth is slow. And the online pharmacy market is small, the growth rate is fast, the compound growth rate reached 84.9 percent in 6 years. By the end of 2016, the CFDA approved 867 Internet drug transaction service certificates. In early 2017, the state council announced to cancel the Internet drug trading services qualification B certificate, C certificate of approval, which means that the legal medicine circulation enterprises are free for the Internet drug B2B, B2C business, medicine, electricity development will be more and more prosperous.
|
| |
Previous article：There are too many tertiary hospitals, and Chinese hospitals will be reshuffled
Next article：Drug access for the first time the state negotiated health care for the drug companies to bargain
|
| |
|
|
